Hyphens Pharma International Ltd
SGX:1J5
Intrinsic Value
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. [ Read More ]
The intrinsic value of one 1J5 stock under the Base Case scenario is hidden SGD. Compared to the current market price of 0.295 SGD, Hyphens Pharma International Ltd is hidden .
Valuation Backtest
Hyphens Pharma International Ltd
Run backtest to discover the historical profit from buying and selling 1J5 stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Hyphens Pharma International Ltd
Current Assets | 92.2m |
Cash & Short-Term Investments | 24.2m |
Receivables | 40.4m |
Other Current Assets | 27.6m |
Non-Current Assets | 28.6m |
PP&E | 4.9m |
Intangibles | 23.6m |
Other Non-Current Assets | 172k |
Current Liabilities | 49.2m |
Accounts Payable | 44.3m |
Other Current Liabilities | 5m |
Non-Current Liabilities | 8.5m |
Long-Term Debt | 4.4m |
Other Non-Current Liabilities | 4.1m |
Earnings Waterfall
Hyphens Pharma International Ltd
Revenue
|
170.6m
SGD
|
Cost of Revenue
|
-108.7m
SGD
|
Gross Profit
|
61.9m
SGD
|
Operating Expenses
|
-49.6m
SGD
|
Operating Income
|
12.3m
SGD
|
Other Expenses
|
-3.7m
SGD
|
Net Income
|
8.6m
SGD
|
Free Cash Flow Analysis
Hyphens Pharma International Ltd
1J5 Profitability Score
Profitability Due Diligence
Hyphens Pharma International Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Hyphens Pharma International Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
1J5 Solvency Score
Solvency Due Diligence
Hyphens Pharma International Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Hyphens Pharma International Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
1J5 Price Targets Summary
Hyphens Pharma International Ltd
According to Wall Street analysts, the average 1-year price target for 1J5 is 0.357 SGD with a low forecast of 0.354 SGD and a high forecast of 0.368 SGD.
Shareholder Return
1J5 Price
Hyphens Pharma International Ltd
Average Annual Return | 17.69% |
Standard Deviation of Annual Returns | 25.83% |
Max Drawdown | -54% |
Market Capitalization | 91.2m SGD |
Shares Outstanding | 300 430 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
Contact
IPO
Employees
Officers
The intrinsic value of one 1J5 stock under the Base Case scenario is hidden SGD.
Compared to the current market price of 0.295 SGD, Hyphens Pharma International Ltd is hidden .